Search Results for: BioView

Lung cancer test for China

I’ve reported several times (see here) on Israeli life sciences company BioView and its innovative cancer detection technology.  BioView has just signed an agreement with Shenzhen China’s Livzon to distribute BioView’s imaging systems in China, Hong Kong, Macau, and Taiwan. … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

A liquid biopsy for cancer

An interview on ILTV Daily with Dr Alan Schwebel, President and CEO of Israel’s BioView, which I reported on previously (see here). Dr Schwebel describes Bioview’s scanning system for early detection of cancer cells and identification of the most appropriate … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

US approves Israeli lung cancer scanner

The US FDA has approved the Duet scanning system, developed by Israeli biotech BioView, for the detection of mutations in lung cancer. http://www.globes.co.il/en/article-fda-approves-bioview-lung-cancer-scanning-system-1000938356 https://www.youtube.com/watch?v=QwlmGH8pTAw

Posted in Israel's Medical Achievements | Leave a comment

A deal to fight cancer

Israeli biotech BioView’s cancer scanning systems will be integrated with French company ScreenCell’s technology to isolate rare tumour cells. The combined solution will improve diagnosis and speed up medical decisions about the best treatment options. http://www.globes.co.il/serveen/globes/docview.asp?did=1000764005&fid=1725

Posted in Israel's Medical Achievements | Leave a comment

Detecting early stage lung cancer

Israeli biotech BioView Ltd has announced that it has signed a cooperation agreement with OncoMDx of California, to develop a non-invasive diagnostic test for the early detection of non-small cell lung cancer (NSCLC). NSCLC accounts for 85% of all lung … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Screening for cancer in Taiwan

Israel’s BioView has sold its first Circulating Tumor Cells (CTC) screening device to Taiwan Academia Sinica for NIS 600,000. BioView’s system distinguishes healthy cells from tumour cells and can diagnose tumours from very small samples. http://www.globes.co.il/serveen/globes/docview.asp?did=1000714359&fid=1725

Posted in Economy & Business | Leave a comment